InsiderClue
Insiders · Profile

Fairman Jeff

VP, Research at Vaxcyte. Filing since 26 Jan 2021. CIK 0001813800

Company
Date
Role
Action
Shares
Amount
Of holding
PCVX Vaxcyte, Inc.
26 Oct 2022
VP, Research
Sold, plan not stated
10,000
$400.00K
3.4%
PCVX Vaxcyte, Inc.
11 Oct 2022
VP, Research
Sold, plan not stated
5,000
$127.50K
1.7%
PCVX Vaxcyte, Inc.
6 Sep 2022
VP, Research
Sold, plan not stated
5,000
$132.89K
1.6%
PCVX Vaxcyte, Inc.
5 Aug 2022
VP, Research
Sold, plan not stated
5,000
$128.51K
1.6%
PCVX Vaxcyte, Inc.
4 Aug 2022
VP, Research
Sold, plan not stated
10,000
$255.00K
3.1%
PCVX Vaxcyte, Inc.
20 May 2022
VP, Research
Sold, plan not stated
4,112
$104.86K
1.3%
PCVX Vaxcyte, Inc.
5 May 2022
VP, Research
Sold, plan not stated
888
$22.91K
0.3%
PCVX Vaxcyte, Inc.
5 Apr 2022
VP, Research
Sold, plan not stated
5,000
$127.95K
1.5%
PCVX Vaxcyte, Inc.
11 Mar 2022
VP, Research
Sold, plan not stated
10,000
$255.00K
2.9%
PCVX Vaxcyte, Inc.
27 Dec 2021
VP, Research
Sold, plan not stated
4,750
$112.09K
43.5%
PCVX Vaxcyte, Inc.
16 Dec 2021
VP, Research
Sold, plan not stated
4,619
$103.93K
42.9%
PCVX Vaxcyte, Inc.
9 Dec 2021
VP, Research
Sold, plan not stated
131
$2.95K
2.1%
PCVX Vaxcyte, Inc.
26 Oct 2021
VP, Research
Sold, plan not stated
4,750
$107.78K
48.0%
PCVX Vaxcyte, Inc.
27 Sep 2021
VP, Research
Sold, plan not stated
4,750
$124.30K
48.0%
PCVX Vaxcyte, Inc.
26 Aug 2021
VP, Research
Sold, plan not stated
4,750
$120.54K
48.0%
PCVX Vaxcyte, Inc.
26 Jul 2021
VP, Research
Sold, plan not stated
4,750
$107.83K
48.0%
PCVX Vaxcyte, Inc.
28 Jun 2021
VP, Research
Sold, plan not stated
4,750
$115.77K
48.0%
PCVX Vaxcyte, Inc.
7 Jun 2021
VP, Research
Sold, plan not stated
9,500
$213.75K
64.9%
PCVX Vaxcyte, Inc.
26 Mar 2021
VP, Research
Sold, plan not stated
4,750
$113.43K
77.1%
PCVX Vaxcyte, Inc.
26 Feb 2021
VP, Research
Sold, plan not stated
4,750
$113.66K
77.1%
PCVX Vaxcyte, Inc.
26 Jan 2021
VP, Research
Sold, plan not stated
4,750
$120.01K
77.1%
21 decisions on file.